Respectively, previous studies have shown that overexpression of the GSK-3β in NSCLC patients regulated cell proliferation, tumourigenesis, apoptosis and cell invasiveness and thus was identified as a risk factor of poor prognosis56. Here, GSK3B is linked to non-small cell lung carcinoma.